Composition for lipolysis using surface-modified gas-generating nanoparticles
A lipolysis and surface modification technology, which is applied in drug combination, drug delivery, cosmetic preparations, etc., can solve side effects and other problems, and achieve the effect of improving or treating obesity and minimizing side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0096] Example 1: Preparation of polylactide-glycolide (PLGA, poly) with surface modification by optimal peptides (P1-P7) (lactide-co-glycolide) gas-generating nanoparticles
[0097] PLGA gas-generating nanoparticles were prepared according to the method disclosed in Example 2 of Korean Patent Publication No. 10-1613606. Surface modification was performed by subjecting the prepared PLGA gas-generating nanoparticles to carbodiimide-bonding reaction with optimal peptides (P1-P7).
[0098] Specifically, PLGA gas-generating nanoparticles (0.5 mM) were suspended in 0.1 M MES buffer (pH 7.0), and EDC (0.5 mM) / sulfo- NHS (0.5mM). The activated PLGA gas-generating nanoparticles were reacted with ethylenediamine (0.5 mM) for one day, washed three times with deionized water, and then resuspended in MES buffer (pH 7.0). To the solution in which the functionalized PLGA gas-generating nanoparticles were suspended, EDC / sulfo-NHS and the optimal peptide described in Table 1 below (the ...
Embodiment 2
[0101] Example 2: 3T3-L1 cell culture and differentiation
[0102] 3T3-L1 undifferentiated cells were cultured in glass bottom cell culture dishes (confocal dishes) or 96-well plates in Dulbecco's modified Eagle's medium (Dulbecco) containing 10% fetal calf serum (BCS, Bovine Calf Serum). 'sModified Eagle's Medium, DMEM) at 37°C, 5% CO 2 conditioned culture. After 3T3-L1 cells were confluenced (confluence), they were grown to day 2 (Day 0), in a growth medium containing 10% fetal bovine serum, using MDI (0.5 μM methylisobutylxanthine, 1 μM dexamethasone and 10 mg / L insulin) were treated for 2 days. Next, after an additional 2 days of treatment in growth medium containing only 10 mg / L of insulin, the growth medium was replaced every 2 days and cultured, and all experiments were started on day 7 after differentiation induction.
Embodiment 3
[0103] Example 3: Analysis of 3T3- of PLGA nanoparticles (PNP) surface-modified by optimal peptides (P1-P5, P7) Intracellular engraftment in L1 cells
[0104] To analyze the 3T3-L1 intracellular engraftment of PLGA nanoparticles surface-modified by the optimal peptides, to the optimal peptides [P1-P5, P7 (in this case, the combination of P1 and P3; molar ratio = 1:1) ] Fluorescent substances were introduced into the surface of the surface-modified PLGA nanoparticles.
[0105] Specifically, the PLGA nanoparticles into which the fluorescent substance (Cy5) was introduced and surface-modified by the optimal peptide [P1-P5, P7 (at this time, the combination of P1 and P3; molar ratio=1:1)] were prepared at 0.5 mg 3T3-L1 cells were treated at a concentration of / ml for 6 hours, and LysoTracker Green DND-26, which stains lysosomes, was added to confirm the engraftment into 3T3-L1 cells. The medium was removed and washed three times with phosphate buffered saline (PBS), fixed wit...
PUM
Property | Measurement | Unit |
---|---|---|
diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com